Citation Impact
Citing Papers
Prevention of Torsade de Pointes in Hospital Settings
2010
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
2007
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
2008
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients
2006
A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity
2014 StandoutNobel
Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel
2002
Effects of Na+ Channel Blocker, Pilsicainide, on HERG Current Expressed in HEK-293 Cells
2003
Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus
2014
Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties
2008
The kynurenine pathway and the brain: Challenges, controversies and promises
2016
Droperidol and ondansetron in vitro electrophysiological drug interaction study
2009
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
2014
Under-Reporting of Adverse Drug Reactions
2006 Standout
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Oxidative stress, redox regulation and diseases of cellular differentiation
2014
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Genetic control of sodium channel function
2003
2-Aminoethoxydiphenyl borate inhibits phototransduction and blocks voltage-gated potassium channels in Limulus ventral photoreceptors
2002
Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice
2006
A Structural Requirement for Processing the Cardiac K+ Channel KCNQ1
2004
The genetic basis of long QT and short QT syndromes: A mutation update
2009
Histamine–cytokine connection in immunity and hematopoiesis
2004
Photodynamic therapy for cancer
2003 Standout
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
2000
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
2002
Coiled Coils Direct Assembly of a Cold-Activated TRP Channel
2006 StandoutNobel
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
2007 StandoutNobel
Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future
2002
Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetium
2002
Store-Operated Calcium Channels
2005 Standout
Canadian guideline for Parkinson disease
2019 Standout
Long-QT Syndrome
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Acute kidney injury
2019 Standout
Postmortem molecular screening in unexplained sudden death
2004
Pharmacogenomics: Challenges and Opportunities
2006
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
2003
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Methadone-induced Torsade de pointes tachycardias
2005
Myocarditis
2011 Standout
Four potassium channel mutations account for 73% of the genetic spectrum underlying long‐QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland
2004
Drug-induced long QT and torsade de pointes: recent advances
2006
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
2009 StandoutNobel
Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement
2005
Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes
2019
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions
2001
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Antipsychotics and QT prolongation
2003
Amino acids and immune function
2007 Standout
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
2005 Standout
Computational investigations of hERG channel blockers: New insights and current predictive models
2015
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Relating protein pharmacology by ligand chemistry
2007 Standout
New Medications for Treatment of Obesity: Metabolic and Cardiovascular Effects
2014
Long QT syndrome: reduced repolarization reserve and the genetic link
2005
Thioridazine and sudden unexplained death in psychiatric in-patients
2002
Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT Syndrome
2003
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug–associated torsades de pointes
2007
Genetic susceptibility to acquired long QT syndrome: Pharmacologic challenge in first-degree relatives
2005
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias
2006
Drug-Induced Prolongation of the QT Interval
2004
European Guidelines for Obesity Management in Adults
2015 Standout
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
Pharmacogenetics of antiarrhythmic therapy
2006
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Acquired QT interval prolongation and HERG: implications for drug discovery and development
2004
Myocarditis
2009 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Fluorine in medicinal chemistry
2007 Standout
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish
2003
Magnesium in Man: Implications for Health and Disease
2014 Standout
Determination of Antioxidants by DPPH Radical Scavenging Activity and Quantitative Phytochemical Analysis of Ficus religiosa
2022 Standout
Cardiac Sodium Channel Gene Variants and Sudden Cardiac Death in Women
2007
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Prolongation of QTc Interval after Postoperative Nausea and Vomiting Treatment by Droperidol or Ondansetron
2005
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Magnesium in Prevention and Therapy
2015 Standout
Ventricular remodelling in rabbits with sustained high‐fat diet
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG‐encoded potassium channel
2009
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Post-acute management of the acquired long QT syndrome
2014
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Near Infrared Imaging and Photothermal Ablation of Vascular Inflammation Using Single‐Walled Carbon Nanotubes
2012
Opioid Complications and Side Effects
2008 Standout
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
2003
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Quantitative Structure−Activity Relationship Studies on Inhibition of HERG Potassium Channels
2006
Characterizing the Severe Reactions of Parenteral Vitamin K1
2016
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
2010
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
2003
Part 14: Pediatric Advanced Life Support
2010 Standout
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
2016
Works of Benoît Drolet being referenced
Galantamine (Reminyl®) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current
2012
Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance
2005
Risperidone Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current
2003
Polymorphism Screening in the Cardiac K+ Channel Gene KCNA5*
2005
Droperidol Lengthens Cardiac Repolarization due to Block of the Rapid Component of the Delayed Rectifier Potassium Current
1999
Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs: A possible ‘anti-proarrhythmic’ role for amlodipine
2011
Impact of Weight-Loss Medications on the Cardiovascular System
2007
Pimozide (Orap®) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current in Native Cardiac Myocytes
2001
In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists.
1998
Sildenafil (Viagra) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current
2000
Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents
2003
Vitamin K Modulates Cardiac Action Potential by Blocking Sodium and Potassium Ion Channels
2000
Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval
1998
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
2002
Block of IKs by the Diuretic Agent Indapamide Modulates Cardiac Electrophysiological Effects of the Class III Antiarrhythmic Drug dl-Sotalol
1997
Thioridazine Lengthens Repolarization of Cardiac Ventricular Myocytes by Blocking the Delayed Rectifier Potassium Current
1999
The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation
2017
Block of Potassium Currents in Guinea Pig Ventricular Myocytes and Lengthening of Cardiac Repolarization in Man by the Histamine H1 Receptor Antagonist Diphenhydramine
1999
Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders
2000